Please activate JavaScript!
Please install Adobe Flash Player, click here for download

kontinenz-aktuell - Ausgabe 01-2015

kontinenz aktuell März/2015 11 OriginalarbeitOriginalarbeit (16) Bortolotti A, Fedele D, Chatenoud L, Colli E, Cos- celli C, Landoni M et al. Cigarette smoking: a risk factor for erectile dysfunction in diabetics. Eur Urol 2001 October; 40 (4): 392–6 (17) Giuliano FA, Leriche A, Jaudinot EO, de Gendre AS. Prevalence of erectile dysfunction among 7,689 patients with diabetes or hypertension, or both. Uro- logy 2004 December; 64 (6): 1196–201 (18) Nicolosi A, Moreira ED, Jr., Shirai M, Bin Mohd Tambi MI, Glasser DB. Epidemiology of erectile dys- function in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 2003 January; 61 (1): 201–6 (19) De BG, Pellegrini F, Franciosi M, Belfiglio M, Di NB, Greenfield S et al. Clinical and psychological predictors of incidence of self-reported erectile dys- function in patients with type 2 diabetes. J Urol 2007 January; 177 (1): 252–7 (20) Demir O, Akgul K, Akar Z, Cakmak O, Ozdemir I, Bolukbasi A et al. Association between severity of lower urinary tract symptoms, erectile dysfunction and metabolic syndrome. Aging Male 2009 March; 12 (1): 29–34 (21) Turek SJ, Hastings SM, Sun JK, King GL, Keenan HA. Sexual dysfunction as a marker of cardiovascu- lar disease in males with 50 or more years of type 1 diabetes. Diabetes Care 2013 October; 36 (10): 3222–6 (22) Dong JY, Zhang YH, Qin LQ. Erectile dysfunction and risk of cardiovascular disease: meta-analysis of prospective cohort studies. J Am Coll Cardiol 2011 September 20; 58 (13): 1378–85 (23) Ponholzer A, Temml C, Obermayr R, Wehrberger C, Madersbacher S. Is erectile dysfunction an indica- tor for increased risk of coronary heart disease and stroke? Eur Urol 2005 September; 48 (3): 512–8 (24) Araujo AB, Travison TG, Ganz P, Chiu GR, Kupeli- an V, Rosen RC et al. Erectile dysfunction and mortality. J Sex Med 2009 September; 6 (9): 2445–54 (25) Giugliano F, Maiorino M, Bellastella G, Gicchi- no M, Giugliano D, Esposito K. Determinants of erectile dysfunction in type 2 diabetes. Int J Impot Res 2010 May; 22 (3): 204–9 (26) Al-Hunayan A, Al-Mutar M, Kehinde EO, Thalib L, Al-Ghorory M. The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus. BJU Int 2007 January; 99 (1): 130–4 (27) Rosen RC, Wing RR, Schneider S, Wadden TA, Foster GD, West DS et al. Erectile dysfunction in type 2 diabetic men: relationship to exercise fitness and cardiovascular risk factors in the Look AHEAD trial. J Sex Med 2009 May; 6 (5): 1414–22 (28) Foresta C, Caretta N, Corona G, Fabbri A, Fran- cavilla S, Jannini E et al. Clinical and metabolic eva- luation of subjects with erectile dysfunction: a review with a proposal flowchart. Int J Androl 2009 June; 32 (3):198–211 (29) Malavige LS, Levy JC. Erectile dysfunction in dia- betes mellitus. J Sex Med 2009 May; 6 (5): 1232–47 (30) Esposito K, Ciotola M, Giugliano F, Schisano B, Improta L, Improta MR et al. Endothelial microparti- cles correlate with erectile dysfunction in diabetic men. Int J Impot Res 2007 March; 19 (2): 161–6 (31) Nehra A, Moreland RB. Neurologic erectile dys- function. Urol Clin North Am 2001 May; 28 (2): 289–308 (32) Saenz dT, I, Angulo J, Cellek S, Gonzalez-Cada- vid N, Heaton J, Pickard R et al. Pathophysiology of erectile dysfunction. J Sex Med 2005 January; 2 (1): 26–39 (33) Dhindsa S, Prabhakar S, Sethi M, Bandyopad- hyay A, Chaudhuri A, Dandona P. Frequent occur- rence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab 2004 November; 89 (11): 5462–8 (34) Kapoor D, Aldred H, Clark S, Channer KS, Jones TH. Clinical and biochemical assessment of hypogonadism in men with type 2 diabetes: correla- tions with bioavailable testosterone and visceral adi- posity. Diabetes Care 2007 April; 30 (4): 911–7 (35) Shabsigh R, Rajfer J, Aversa A, Traish AM, Yas- sin A, Kalinchenko SY et al. The evolving role of tes- tosterone in the treatment of erectile dysfunction. Int J Clin Pract 2006 September; 60 (9): 1087–92 (36) Bellastella G, Maiorino MI, Olita L, De BA, Giu- gliano D, Esposito K. Anti-pituitary antibodies and hypogonadotropic hypogonadism in type 2 diabe- tes: in search of a role. Diabetes Care 2013 August; 36 (8): e116–e117 (37) Heufelder AE, Saad F, Bunck MC, Gooren L. Fifty- two-week treatment with diet and exercise plus trans- dermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly di- agnosed type 2 diabetes and subnormal plasma tes- tosterone. J Androl 2009 November; 30 (6): 726–33 (38) Zitzmann M. Effects of testosterone replacement and its pharmacogenetics on physical performance and metabolism. Asian J Androl 2008 May; 10 (3): 364–72 (39) Montague DK, Jarow J, Broderick GA, Dmo- chowski RR, Heaton JP, Lue TF et al. AUA guideline on the pharmacologic management of premature ejacula- tion. J Urol 2004 July; 172 (1): 290–4 (40) Zhang X, Gao J, Liu J, Xia L, Yang J, Hao Z et al. Distribution and factors associated with four premature ejaculation syndromes in outpatients complaining of ejaculating prematurely. J Sex Med 2013 June; 10 (6): 1603–11 (41) Malavige LS, Wijesekara P, Seneviratne ED, Ra- nasinghe P, Levy JC. Ethnic differences in sexual dys- function among diabetic and nondiabetic males: the Oxford Sexual Dysfunction Study. J Sex Med 2013 February; 10 (2): 500–8 (42) Malavige LS, Jayaratne SD, Kathriarachchi ST, Si- vayogan S, Fernando DJ, Levy JC. Erectile dysfunction among men with diabetes is strongly associated with premature ejaculation and reduced libido. J Sex Med 2008 September; 5 (9): 2125–34 (43) Corona G, Giorda CB, Cucinotta D, Guida P, Nada E. Sexual dysfunction at the onset of type 2 dia- betes: the interplay of depression, hormonal and car- diovascular factors. J Sex Med 2014 August; 11 (8): 2065–73 (44) Regier DA, Kuhl EA, Kupfer DJ. The DSM-5: Clas- sification and criteria changes. World Psychiatry 2013 June; 12 (2): 92–8 (45) Kupfer DJ, Kuhl EA, Regier DA. DSM-5--the future arrived. JAMA 2013 April 24; 309 (16): 1691–2 (46) Rosen R, Brown C, Heiman J, Leiblum S, Meston C, Shabsigh R et al. The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function. J Sex Marital Ther 2000 April; 26 (2): 191–208 (47) Shifren JL, Monz BU, Russo PA, Segreti A, Johan- nes CB. Sexual problems and distress in United States women: prevalence and correlates. Obstet Gynecol 2008 November; 112 (5): 970–8 (48) Dennerstein L, Randolph J, Taffe J, Dudley E, Bur- ger H. Hormones, mood, sexuality, and the menopau- sal transition. Fertil Steril 2002 April; 77 Suppl 4: S42–S48 (49) Lindau ST, Schumm LP, Laumann EO, Levinson W, O’Muircheartaigh CA, Waite LJ. A study of se- xuality and health among older adults in the United States. N Engl J Med 2007 August 23; 357 (8): 762–74 (50) Abu Ali RM, Al Hajeri RM, Khader YS, Shegem NS, Ajlouni KM. Sexual dysfunction in Jordanian diabetic women. Diabetes Care 2008 August; 31 (8): 1580–1 (51) Esposito K, Maiorino MI, Bellastella G, Giuglia- no F, Romano M, Giugliano D. Determinants of female sexual dysfunction in type 2 diabetes. Int J Impot Res 2010 May; 22 (3): 179–84 (52) Eyada M, Atwa M. Sexual function in female patients with unstable angina or non-ST-elevation myocardial infarction. J Sex Med 2007 September; 4 (5): 1373–80 (53) Doumas M, Tsiodras S, Tsakiris A, Douma S, Chounta A, Papadopoulos A et al. Female sexual dysfunction in essential hypertension: a common pro- blem being uncovered. J Hypertens 2006 Decem- ber; 24 (12): 2387–92 (54) Krychman M, Millheiser LS. Sexual health issues in women with cancer. J Sex Med 2013 February; 10 Suppl 1: 5–15 (55) Peng YS, Chiang CK, Kao TW, Hung KY, Lu CS, Chiang SS et al. Sexual dysfunction in female hemo- dialysis patients: a multicenter study. Kidney Int 2005 August; 68 (2): 760–5 (56) Moore RH, Sarwer DB, Lavenberg JA, Lane IB, Evans JL, Volger S et al. Relationship between sexual function and quality of life in obese persons seeking weight reduction. Obesity (Silver Spring) 2013 October; 21 (10): 1966–74 (57) Kadioglu P, Yetkin DO, Sanli O, Yalin AS, Onem K, Kadioglu A. Obesity might not be a risk factor for female sexual dysfunction. BJU Int 2010 November; 106 (9): 1357–61 (58) Bond DS, Vithiananthan S, Leahey TM, Thomas JG, Sax HC, Pohl D et al. Prevalence and degree of sexual dysfunction in a sample of women seeking bariatric surgery. Surg Obes Relat Dis 2009 Novem- ber; 5 (6): 698–704 (59) Martelli V, Valisella S, Moscatiello S, Matteucci C, Lantadilla C, Costantino A et al. Prevalence of sexual dysfunction among postmenopausal women with and without metabolic syndrome. J Sex Med 2012 February; 9 (2): 434–41 (60) Pontiroli AE, Cortelazzi D, Morabito A. Female sexual dysfunction and diabetes: a systematic review and meta-analysis. J Sex Med 2013 April; 10 (4): 1044–51 (61) Meeking D, Fosbury J, Cradock S. Assessing the impact of diabetes on female sexuality. Commu- nity Nurse 1997 September; 3 (8): 50–2 (62) Giraldi A, Persson K, Werkstrom V, Alm P, Wag- ner G, Andersson KE. Effects of diabetes on neuro- transmission in rat vaginal smooth muscle. Int J Impot Res 2001 April; 13 (2): 58–66 (63) Muniyappa R, Norton M, Dunn ME, Banerji MA. Diabetes and female sexual dysfunction: mo- ving beyond „benign neglect“. Curr Diab Rep 2005 June; 5 (3): 230–6 (64) Park K, Ahn K, Chang JS, Lee SE, Ryu SB, Park YI. Diabetes induced alteration of clitoral hemodyna- mics and structure in the rabbit. J Urol 2002 Septem- ber; 168 (3): 1269–72 (65) Feldhaus-Dahir M. The causes and prevalence of hypoactive sexual desire disorder: part I. Urol Nurs 2009 July; 29 (4): 259–60, 263 Reference List kontinenz aktuell März/201511